SCHEMBL3434009

SCHEMBL3434009

c1cc([C@@H]2CCCCN2)ccc1OCN1CCCCC1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 13/20 0.48
KCNH2 Q12809 6/20 0.48
CYP2C9 P11712 4/20 0.41
CYP3A4 P08684 3/20 0.41
LTA4H P09960 1/20 0.41
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
MEN1 O00255 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 2/20 0.40
KMT2A Q03164 2/20 0.40
POLB P06746 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNA7 P36544 1/20 0.40
CHRNA4 P43681 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2A6 P11509 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13499189 0.79 HRH3 (0.55) HRH3MEN1CYP2D6CYP2C19KMT2A
SCHEMBL7549907 0.78 HRH3 (0.47) HRH3KCNH2CYP2C9LTA4HESR1
SCHEMBL8542490 0.75 MEN1 (0.53) CYP2C9MEN1CYP2D6CYP2C19KMT2A
SCHEMBL4599631 0.75 MEN1 (0.53) CYP2C9MEN1CYP2D6CYP2C19KMT2A
SCHEMBL7554518 0.75 HRH3 (0.53) HRH3LTA4HMEN1KMT2A
SCHEMBL13499191 0.75 HRH3 (0.56) HRH3MEN1CYP2D6CYP2C19KMT2A
SCHEMBL21427 0.74 NQO1 (0.47) LTA4HMEN1KMT2ACHRNB2CHRNA7
SCHEMBL3348073 0.73 MEN1 (0.54) CYP2C9MEN1CYP2D6CYP2C19KMT2A
SCHEMBL30748884 0.71 LTA4H (0.57) KCNH2CYP2C9LTA4HMEN1CYP2D6
SCHEMBL8385088 0.70 LTA4H (0.44) CYP2C9LTA4HMEN1CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010049678-A2 TREATMENT OF ENERGY UTILIZATION DISEASES SUMMIT CORPORATION PLC (GB) 2010-05-06 WO disclosed